-
Company Insights
Innovation and Patenting activity of Intact Financial Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Intact Financial Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Adenoid Cystic Carcinoma (ACC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Decoy-20 in Adenoid Cystic Carcinoma (ACC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Adenoid Cystic Carcinoma (ACC) Drug Details: Decoy-20...
-
Sector Analysis
Cartilage Repair Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Cartilage Repair Market Report Overview The cartilage repair market size was $76.3 million in 2023. The market is expected to grow at a CAGR of less than 1% during 2023 and 2033. Cartilage repair procedures aim to regenerate, restore, or replace articular cartilage to reduce joint pain and prevent the development of arthritis. Cartilage Repair Market Outlook, 2023-2033 ($ Million) Buy Full Report for More Insights into The Cartilage Repair Market Forecast Download a Free Report Sample The cartilage repair...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Colorectal Cancer Drug Details: Decoy-20 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Hepatocellular Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Hepatocellular Carcinoma Drug Details: Decoy-20 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Bladder Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Bladder Carcinoma Drug Details: Decoy-20 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Pancreatic Cancer Drug Details: Decoy-20 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Cervical Cancer Drug Details: Decoy-20 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Decoy-20 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Decoy-20 in Solid Tumor Drug Details: Decoy-20 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ICON-1 in Choroidal Neovascularization
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ICON-1 in Choroidal Neovascularization report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary...